23 research outputs found
ΠΠΎΠ²Π΅ΡΡ Π½ΠΎΡΡΠ½ΡΠ΅ ΠΈ ΠΎΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° Π±ΡΠΌΠ°Π³ΠΈ, ΡΠΎΠ΄Π΅ΡΠΆΠ°ΡΠ΅ΠΉ ΠΊΠ°ΡΠ±ΠΎΠ½Π°Ρ ΠΊΠ°Π»ΡΡΠΈΡ
The article investigates the surface and optical properties of calcium carbonate paper obtained at the UzbekChinese enterprise Fergana stone paper company (Uzbekistan), in order to identify the possibility of their use at printing enterprises for printing multicolor products using traditional printing methods. According to the results of a quantitative assessment of the surface quality by the indirect Beck method, we can say that paper sample 1 has a smoothness like coated paper (750β1500 s), paper samples 2 and 3 β like calendered paper, so that these paper samples can be recommended for prints with increased quality requirements. Smaller values of roughness Ra and small depressions, expressed by darkening in the topographic AFM images, characterized sufficient homogeneity and density of the structure. It was also revealed that the surface of the paper samples has a high ability to specularly reflect the incident light, since the percentage of surface reflection is similar to that of coated papers. Samples of paper have a whiteness of about 90 % and do not have a tint, since the difference between the maximum and minimum values of the reflection coefficients on a white stack is not more than 10 %. The tested paper samples can be recommended without restrictions for double-sided printing, since the opacity index is more than 92 %.ΠΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½Ρ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠ½ΡΠ΅ ΠΈ ΠΎΠΏΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ ΡΠ²ΠΎΠΉΡΡΠ²Π° Π±ΡΠΌΠ°Π³ΠΈ ΠΈΠ· ΠΊΠ°ΡΠ±ΠΎΠ½Π°ΡΠ° ΠΊΠ°Π»ΡΡΠΈΡ, ΠΏΠΎΠ»ΡΡΠ΅Π½Π½ΠΎΠΉ Π² ΡΡΠ»ΠΎΠ²ΠΈΡΡ
Π£Π·Π±Π΅ΠΊΡΠΊΠΎ-ΠΊΠΈΡΠ°ΠΉΡΠΊΠΎΠ³ΠΎ ΠΏΡΠ΅Π΄ΠΏΡΠΈΡΡΠΈΡ Fergana stone paper company (Π£Π·Π±Π΅ΠΊΠΈΡΡΠ°Π½), Ρ ΡΠ΅Π»ΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡΠΈ Π΅Π΅ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΡ Π½Π° ΠΏΠΎΠ»ΠΈΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΏΡΠ΅Π΄ΠΏΡΠΈΡΡΠΈΡΡ
Π΄Π»Ρ ΠΏΠ΅ΡΠ°ΡΠΈ ΠΌΠ½ΠΎΠ³ΠΎΠΊΡΠ°ΡΠΎΡΠ½ΠΎΠΉ ΠΏΡΠΎΠ΄ΡΠΊΡΠΈΠΈ Ρ ΠΏΡΠΈΠΌΠ΅Π½Π΅Π½ΠΈΠ΅ΠΌ ΡΡΠ°Π΄ΠΈΡΠΈΠΎΠ½Π½ΡΡ
ΡΠΏΠΎΡΠΎΠ±ΠΎΠ² ΠΏΠ΅ΡΠ°ΡΠΈ. ΠΠΎ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ°ΠΌ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠΉ ΠΎΡΠ΅Π½ΠΊΠΈ ΠΊΠ°ΡΠ΅ΡΡΠ²Π° ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠΈ ΠΊΠΎΡΠ²Π΅Π½Π½ΡΠΌ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ ΠΠ΅ΠΊΠ° ΠΌΠΎΠΆΠ½ΠΎ ΡΡΠ²Π΅ΡΠΆΠ΄Π°ΡΡ, ΡΡΠΎ ΠΎΠ±ΡΠ°Π·Π΅Ρ Π±ΡΠΌΠ°Π³ΠΈ β 1 ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ Π³Π»Π°Π΄ΠΊΠΎΡΡΡΡ, ΠΊΠ°ΠΊ Ρ ΠΌΠ΅Π»ΠΎΠ²Π°Π½Π½ΠΎΠΉ Π±ΡΠΌΠ°Π³ΠΈ (750β1500 Ρ), ΠΎΠ±ΡΠ°Π·ΡΡ Π±ΡΠΌΠ°Π³ΠΈ β 2 ΠΈ 3, ΠΊΠ°ΠΊ Ρ Π±ΡΠΌΠ°Π³ ΠΊΠ°Π»Π°Π½Π΄ΡΠΈΡΠΎΠ²Π°Π½Π½ΡΡ
, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΌΠΎΠΆΠ½ΠΎ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°ΡΡ Π΄Π»Ρ ΠΈΠ·Π΄Π°Π½ΠΈΠΉ Ρ ΠΏΠΎΠ²ΡΡΠ΅Π½Π½ΡΠΌΠΈ ΡΡΠ΅Π±ΠΎΠ²Π°Π½ΠΈΡΠΌΠΈ ΠΊ ΠΊΠ°ΡΠ΅ΡΡΠ²Ρ. ΠΠ΅Π½ΡΡΠΈΠ΅ Π·Π½Π°ΡΠ΅Π½ΠΈΡ ΡΠ΅ΡΠΎΡ
ΠΎΠ²Π°ΡΠΎΡΡΠΈ Ra ΠΈ Π½Π΅Π±ΠΎΠ»ΡΡΠΈΠ΅ ΡΠ³Π»ΡΠ±Π»Π΅Π½ΠΈΡ, Π²ΡΡΠ°ΠΆΠ΅Π½Π½ΡΠ΅ Π·Π°ΡΠ΅ΠΌΠ½Π΅Π½ΠΈΠ΅ΠΌ Π½Π° ΡΠΎΠΏΠΎΠ³ΡΠ°ΡΠΈΡΠ΅ΡΠΊΠΈΡ
ΠΠ‘Π-ΠΈΠ·ΠΎΠ±ΡΠ°ΠΆΠ΅Π½ΠΈΡΡ
, Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΠ·ΠΎΠ²Π°Π»ΠΈ Π΄ΠΎΡΡΠ°ΡΠΎΡΠ½ΡΡ ΠΎΠ΄Π½ΠΎΡΠΎΠ΄Π½ΠΎΡΡΡ ΠΈ ΠΏΠ»ΠΎΡΠ½ΠΎΡΡΡ ΡΡΡΡΠΊΡΡΡΡ. Π’Π°ΠΊΠΆΠ΅ Π²ΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΡ ΠΎΠ±ΡΠ°Π·ΡΠΎΠ² Π±ΡΠΌΠ°Π³ΠΈ ΠΎΠ±Π»Π°Π΄Π°Π΅Ρ Π²ΡΡΠΎΠΊΠΎΠΉ ΡΠΏΠΎΡΠΎΠ±Π½ΠΎΡΡΡΡ Π·Π΅ΡΠΊΠ°Π»ΡΠ½ΠΎ ΠΎΡΡΠ°ΠΆΠ°ΡΡ ΠΏΠ°Π΄Π°ΡΡΠΈΠΉ ΡΠ²Π΅Ρ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΏΡΠΎΡΠ΅Π½Ρ ΠΎΡΡΠ°ΠΆΠ΅Π½ΠΈΡ ΠΏΠΎΠ²Π΅ΡΡ
Π½ΠΎΡΡΠ΅ΠΉ ΡΠ°ΠΊΠΎΠΉ ΠΆΠ΅, ΠΊΠ°ΠΊ Ρ ΠΌΠ΅Π»ΠΎΠ²Π°Π½Π½ΡΡ
Π±ΡΠΌΠ°Π³. ΠΠ±ΡΠ°Π·ΡΡ Π±ΡΠΌΠ°Π³ΠΈ ΠΈΠΌΠ΅ΡΡ Π±Π΅Π»ΠΈΠ·Π½Ρ ΠΏΠΎΡΡΠ΄ΠΊΠ° 90 % ΠΈ Π½Π΅Ρ ΠΎΡΡΠ΅Π½ΠΊΠ°, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΡΠ°Π·Π½ΠΈΡΠ° ΠΌΠ΅ΠΆΠ΄Ρ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡΠ½ΡΠΌ ΠΈ ΠΌΠΈΠ½ΠΈΠΌΠ°Π»ΡΠ½ΡΠΌ Π·Π½Π°ΡΠ΅Π½ΠΈΡΠΌΠΈ ΠΊΠΎΡΡΡΠΈΡΠΈΠ΅Π½ΡΠΎΠ² ΠΎΡΡΠ°ΠΆΠ΅Π½ΠΈΡ Π½Π° Π±Π΅Π»ΠΎΠΉ ΡΡΠΎΠΏΠ΅ Π½Π΅ Π±ΠΎΠ»ΡΡΠ΅ 10 %. ΠΡΡΠ»Π΅Π΄ΡΠ΅ΠΌΡΠ΅ ΠΎΠ±ΡΠ°Π·ΡΡ Π±ΡΠΌΠ°Π³ΠΈ ΠΌΠΎΠΆΠ½ΠΎ Π±Π΅Π· ΠΎΠ³ΡΠ°Π½ΠΈΡΠ΅Π½ΠΈΠΉ ΡΠ΅ΠΊΠΎΠΌΠ΅Π½Π΄ΠΎΠ²Π°ΡΡ Π΄Π»Ρ Π΄Π²ΡΡΡΠΎΡΠΎΠ½Π½Π΅ΠΉ ΠΏΠ΅ΡΠ°ΡΠΈ, ΡΠ°ΠΊ ΠΊΠ°ΠΊ ΠΏΠΎΠΊΠ°Π·Π°ΡΠ΅Π»Ρ ΡΠ²Π΅ΡΠΎΠ½Π΅ΠΏΡΠΎΠ½ΠΈΡΠ°Π΅ΠΌΠΎΡΡΠΈ Π±ΠΎΠ»ΡΡΠ΅ 92 %
Antibiotic therapy of chronic prostatitis in elderly and senile age
The etiological structure of chronic bacterial prostatitis in 110 of patients of elderly and senile age was studied. It was noted, that the agents of this nosology were in most of the cases - conditional-pathogenic pathogens of the family Enterobacteriaceae. Considering the clinical and microbiological efficacy, safety and tolerability of the antibiotic, the drug of choice of antibacterial therapy is a new generation fluoroquinolone - levofloxacin, which meets the requirements of the WHO.ΠΠ·ΡΡΠ΅Π½Π° ΡΡΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΡΡΡΠΊΡΡΡΠ° Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΡ
Π±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΡΡ
ΠΏΡΠΎΡΡΠ°ΡΠΈΡΠΎΠ² Ρ 110 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠ² ΠΏΠΎΠΆΠΈΠΏΠΎΠ³ΠΎ ΠΈ ΡΡΠ°ΡΡΠ΅ΡΠΊΠΎΠ³ΠΎ Π²ΠΎΠ·ΡΠ°ΡΡΠ°. Π£ΡΡΠ°Π½ΠΎΠ²ΠΏΠ΅Π½ΠΎ, ΡΡΠΎ Π² Π±ΠΎΠ»ΡΡΠΈΠ½ΡΡΠ²Π΅ ΡΠ»ΡΡΠ°Π΅Π² Π²ΠΎΠ·Π±ΡΠ΄ΠΈΡΠ΅Π»ΡΠΌΠΈ Π΄Π°Π½Π½ΠΎΠΉ Π½ΠΎΠ·ΠΎΠ»ΠΎΠ³ΠΈΠΈ ΡΠ²Π»ΡΡΡΡΡ ΡΡΠ»ΠΎΠ²Π½ΠΎ-ΠΏΠ°ΡΠΎΠ³Π΅Π½Π½ΡΠ΅ ΠΌΠΈΠΊΡΠΎΠΎΡΠ³Π°Π½ΠΈΠ·ΠΌΡ ΡΠ΅ΠΌΠ΅ΠΉΡΡΠ²Π° ΡΠ½ΡΠ΅ΡΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΠΉ. Π£ΡΠΈΡΡΠ²Π°Ρ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΌΠΈΠΊΡΠΎΠ±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΡΡ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ, Π±Π΅Π·ΠΎΠΏΠ°ΡΠ½ΠΎΡΡΡ ΠΈ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠΈΠΌΠΎΡΡΡ Π°Π½ΡΠΈΠ±ΠΈΠΎΡΠΈΠΊΠ° ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ Π²ΡΠ±ΠΎΡΠ° Π°Π½ΡΠΈΠ±Π°ΠΊΡΠ΅ΡΠΈΠ°Π»ΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΡΠ²Π»ΡΠ΅ΡΡΡ ΡΡΠΎΡΡ
ΠΈΠ½ΠΎΠ»ΠΎΠ½ Π½ΠΎΠ²ΠΎΠ³ΠΎ ΠΏΠΎΠΊΠΎΠ»Π΅Π½ΠΈΡ Π»Π΅Π²ΠΎΡΠ»ΠΎΠΊΡΠ°ΡΠΈΠ½, ΠΎΡΠ²Π΅ΡΠ°ΡΡΠΈΠΉ ΡΡΠ΅Π±ΠΎΠ²Π°Π½ΠΈΡΠΌ ΠΠΠ
THE INFLUENCE OF METABOLIC SYNDROME ON HEART ABNORMALITIES IN PATIENTS WITH ARTERIAL HYPERTENSION
Aim: To evaluate structural and functional heart abnormalities in patients with arterial hypertension (AH) with and without metabolic syndrome.Materials and methods: The study included 303Β patients with AH I, II and III, aged from 25 toΒ 70Β years (meanΒ±SD 52Β±18 years). All patients were categorized into 3 groups according to severity of AH (AH I, II and III corresponded to groups 1, 2 and 3, respectively). Within each group, patients were subdivided into 2 subgroups: without metabolic syndrome (n=151) and with metabolic syndrome (n=152). Assessments included measurements of blood glucose and lipids, 24-hour monitoring of blood pressure, echocardiography with calculation of myocardial mass index of left ventricle and the use of conventional and tissue myocardial dopplerography.Results: Already at early stage of AH (gr. I), 60% patients with metabolic syndrome and 32% patients without metabolic abnormalities had some degree of left ventricular remodeling, including concentric type of remodeling in 12 and 20%, excentric hypertrophy in 18 and 6%, concentric left ventricular hypertrophy in 30 and 6%, respectively. In AH I, an increase of myocardial mass index of left ventricle was found in 39% of patients with metabolic syndrome and in 12% patients without it. In patients with AH I, abnormalities of left ventricular diastolic function according to the results of tissue myocardial dopplerography was seen in 82% of patients with metabolic syndrome and in 42% of patients without metabolic syndrome. Patients with AH IβIII and metabolic syndrome had almost 5-fold higher probability of heart abnormalities than AH patients without metabolic disturbances (odds ratio 4.8, 95% confidence interval 1.9β6.4, p< 50 and>50 years).Conclusion: Metabolic syndrome contributes to heart abnormalities irrespective of gender, age and AH grade
MONITORING OF THE ENVIRONMENTAL STATE OF THE RIVERS OF THE CHECHEN REPUBLIC
The ecological status of the river Argun and Squirrel. It is shown that the Argun River and Squirrel are classified as "moderately polluted" water quality class III. The basic measures to protect water resources from pollutants CR
Heart pathology in patients with arterial hypertension and metabolic syndrome
Aim: To study the specifics of heart pathology in patients with Stage I-III arterial hypertension (AH) and present or absent metabolic syndrome (MS).Material and methods: The study included 303 patients with Stage I-III AH and MS, aged 25-70 years (mean age 52Β±18 years); 110 men and 193 women. All patients were divided into 2 groups (AH+MS and AH-MS) by MS presence or absence, respectively. The groups were comparable by sex and age distribution. Each group was also divided into three subgroups by AH stage (I-III). Left ventricular (LV) diastolic dysfunction (DD) was assessed by transmitral flow dopplerography (TFD), pulmonary vein dopplerography (PVD), and impulse-wave myocardial tissue dopplerography (MTD).Results: In patients with AH and MS, LV myocardial mass increase and LV remodelling were observed at earlier AH stage, comparing to MS-free hypertensive patients. MTD demonstrated early LV diastolic dysfunction in 85 % and 88 % of the Stage I and Stage II AH patients, respectively. For TFD method, these figures were 33 % and 44 %, respectively.Conclusion. The combination of MS and Stage I-III AH, comparing to AH only, was characterized by more severe LV diastolic dysfunction and LV remodelling at early stages of the disease